drugset / Trial / NCT05129176

Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

NCT05129176

Phase 4 Unknown 106 enrolled Shandong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare the effectiveness of levofloxacin-tetracycline -containing and metronidazole-tetracycline-containing quadruple regimens for the primary treatment of Helicobacter pylori infection in patients allergic to penicillin.

Timeline

Start
2021-11-23
Primary completion
2022-07
Completion
2022-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 500 mg Oral
Comparator Metronidazole Small molecule 400 mg Oral